Trials / Completed
CompletedNCT00845520
Safety and Effectiveness of the Calhoun Vision Light Adjustable Intraocular Lens (LAL)
A Prospective Multi-center Clinical Study to Evaluate the Safety and Effectiveness of the Light Adjustable Lens (LAL) in Subjects Undergoing Cataract Extraction
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 74 (actual)
- Sponsor
- Calhoun Vision, Inc. · Industry
- Sex
- All
- Age
- 40 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
The primary objective of this study is to evaluate, for the visual correction of aphakia, the safety and effectiveness of the Calhoun Vision Light Adjustable intraocular lens (LAL) and Light Delivery Device (LDD) in treating postoperative residual refractive error by providing a stable, targeted refractive adjustment of the LAL power and lock-in treatments with the LDD.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Lens implantation +1.00 D postop target | Lens implantation +1.00 D postoperative MRSE target. Light Delivery Device treatment based on postoperative manifest refraction. |
| DEVICE | Lens implantation -1.00 D postop target | Lens implantation -1.00 D postoperative MRSE target. Light Delivery Device treatment based on postoperative manifest refraction. |
| DEVICE | Lens implantation 0.00 D postop target | Lens implantation 0.00 D postoperative MRSE target. Light Delivery Device treatment based on postoperative manifest refraction. |
Timeline
- Start date
- 2009-01-01
- Primary completion
- 2013-03-01
- Completion
- 2013-03-01
- First posted
- 2009-02-18
- Last updated
- 2018-07-06
- Results posted
- 2018-07-06
Locations
6 sites across 2 countries: United States, Mexico
Source: ClinicalTrials.gov record NCT00845520. Inclusion in this directory is not an endorsement.